J.M. Extra

747 total citations
33 papers, 430 citations indexed

About

J.M. Extra is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.M. Extra has authored 33 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.M. Extra's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Genomics and Diagnostics (6 papers). J.M. Extra is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Genomics and Diagnostics (6 papers). J.M. Extra collaborates with scholars based in France, Sweden and Japan. J.M. Extra's co-authors include Marc Espié, M. Marty, Sylvie Giacchetti, Véronique Dièras, F. Morvan, L. Mignot, J-Y Pierga, E. Bourstyn, Éric Bellissant and Patricia Tresca and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Heart Journal.

In The Last Decade

J.M. Extra

32 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Extra France 11 306 175 101 63 57 33 430
A. Romero Argentina 9 437 1.4× 136 0.8× 96 1.0× 118 1.9× 56 1.0× 13 525
D Warren United States 7 260 0.8× 138 0.8× 75 0.7× 74 1.2× 38 0.7× 12 364
C Lynch United States 6 324 1.1× 104 0.6× 49 0.5× 73 1.2× 40 0.7× 6 460
Mario Rabinovich Argentina 11 339 1.1× 114 0.7× 65 0.6× 109 1.7× 42 0.7× 17 467
E Reich United States 7 266 0.9× 137 0.8× 52 0.5× 77 1.2× 31 0.5× 7 353
S Wolff United States 4 307 1.0× 107 0.6× 74 0.7× 48 0.8× 39 0.7× 6 408
BC Lembersky United States 8 295 1.0× 160 0.9× 34 0.3× 169 2.7× 47 0.8× 14 442
Anna Maria Mosconi Italy 13 364 1.2× 134 0.8× 59 0.6× 90 1.4× 140 2.5× 39 558
Marie-Thérèse Closon Belgium 5 420 1.4× 180 1.0× 31 0.3× 79 1.3× 23 0.4× 8 454
Anne Favret United States 8 272 0.9× 132 0.8× 27 0.3× 120 1.9× 37 0.6× 16 365

Countries citing papers authored by J.M. Extra

Since Specialization
Citations

This map shows the geographic impact of J.M. Extra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Extra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Extra more than expected).

Fields of papers citing papers by J.M. Extra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Extra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Extra. The network helps show where J.M. Extra may publish in the future.

Co-authorship network of co-authors of J.M. Extra

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Extra. A scholar is included among the top collaborators of J.M. Extra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Extra. J.M. Extra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabatier, Renaud, J.M. Extra, Carole Tarpin, et al.. (2017). Untreated hormone receptor positive/HER2-negative metastatic breast cancer survival with front-line chemotherapy and maintenance endocrine therapy. Annals of Oncology. 28. v88–v88. 1 indexed citations
2.
Giacchetti, Sylvie, Raphaël Porcher, Jacqueline Lehmann‐Che, et al.. (2014). Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen. British Journal of Cancer. 110(6). 1413–1419. 20 indexed citations
3.
Seror, Valérie, Patricia Marino, François Bertucci, et al.. (2013). Breast Cancer Patients' Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy. Public Health Genomics. 16(3). 110–117. 8 indexed citations
4.
Gonçalvès, Anthony, Étienne Brain, Carole Tarpin, et al.. (2012). Abstract OT2-3-05: AVASTEM: a phase II randomized trial evaluating anti-cancer stem cell activity of pre-operative bevacizumab and chemotherapy in breast cancer. Cancer Research. 72(24_Supplement). OT2–3. 3 indexed citations
5.
Extra, J.M., J Jacquemier, Max Buttarelli, et al.. (2009). Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy. European Journal of Surgical Oncology. 35(9). 916–920. 23 indexed citations
6.
Gonçalves, A., R. Delva, Michel Fabbro, et al.. (2006). Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study. Bone Marrow Transplantation. 37(7). 651–659. 2 indexed citations
7.
Marty, M., Stephen Chan, J.M. Extra, & Brian Leyland‐Jones. (2005). Anthracyclines vs taxanes plus trastuzumab in HER2-positive metastatic breast cancer (MBC): A cross trial comparison of pivotal studies. Journal of Clinical Oncology. 23(16_suppl). 743–743. 1 indexed citations
8.
Viens, Patrice, Thomas Petit, Alejandro Yovine, et al.. (2004). Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) inplatinum + taxanes sensitive advanced ovarian cancer (AOC) patients: Final results. Journal of Clinical Oncology. 22(14_suppl). 5023–5023. 6 indexed citations
9.
Cottu, Paul, et al.. (2001). Residual Tumor Cell Contamination in Peripheral Blood Stem Cells Collections of 117 Breast Cancer Patients Evaluated by Immunocytochemical Technique. Journal of Hematotherapy & Stem Cell Research. 10(6). 855–862. 4 indexed citations
10.
Cottu, P., J.M. Extra, Marc Espié, et al.. (2001). High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study. British Journal of Cancer. 85(9). 1240–1246. 6 indexed citations
11.
Pierga, J-Y, E. Bourstyn, Claude Nos, et al.. (1999). Detection of circulating MUC1-positive cells in breast cancer. Breast Cancer Research and Treatment. 57(1). 120. 2 indexed citations
12.
Cottu, Paul, Laurent Zelek, J.M. Extra, et al.. (1999). High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients. Annals of Oncology. 10(7). 795–802. 10 indexed citations
13.
Dièras, Véronique, J.M. Extra, Éric Bellissant, et al.. (1996). Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.. Journal of Clinical Oncology. 14(12). 3097–3104. 64 indexed citations
14.
Debourdeau, P., Guy Meyer, Zora Marjanovic, et al.. (1996). Traitement anticoagulant classique de la maladie thromboembolique veineuse chez les patients cancéreux. À propos d'une série rétrospective de 71 patients. La Revue de Médecine Interne. 17(3). 207–212. 9 indexed citations
15.
Pierga, J-Y, et al.. (1994). Dysgerminoma in a Pure 45,X Turner Syndrome: Report of a Case and Review of the Literature. Gynecologic Oncology. 55(3). 459–464. 10 indexed citations
16.
Faille, A, Patricia de Crémoux, J.M. Extra, et al.. (1994). p53 mutations and overexpression in locally advanced breast cancers. British Journal of Cancer. 69(6). 1145–1150. 61 indexed citations
17.
Raymond, Émilie, et al.. (1994). Métastases oculaires. Revue de la littérature à propos de quatre observations. La Revue de Médecine Interne. 15(5). 318–324. 2 indexed citations
18.
Marty, M., et al.. (1992). A Review of the Antitumour Activity of Vinorelbine in Breast Cancer. Drugs. 44(Supplement 4). 29–35. 24 indexed citations
19.
Brice, Pauline, E. Bourstyn, M F D'Agay, et al.. (1991). Surgical restaging of advanced Hodgkin's disease after first line chemotherapy. European Journal Of Haematology. 46(5). 306–311. 2 indexed citations
20.
Monsuez, Jean-Jacques, et al.. (1991). Non-Hodgkin's lymphoma with cardiac presentation: evaluation and follow-up with echocardiography and MR imaging. European Heart Journal. 12(3). 464–467. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Romero Breakdown of academic impact, for papers by D Warren Breakdown of academic impact, for papers by C Lynch Breakdown of academic impact, for papers by Mario Rabinovich Breakdown of academic impact, for papers by E Reich Breakdown of academic impact, for papers by S Wolff Breakdown of academic impact, for papers by BC Lembersky Breakdown of academic impact, for papers by Anna Maria Mosconi Breakdown of academic impact, for papers by Marie-Thérèse Closon Breakdown of academic impact, for papers by Anne Favret
Rankless by CCL
2026